Brief: Sunesis Pharmaceuticals Reports Qtrly Loss Per Share $0.06
Aug 11 (Reuters) - Sunesis Pharmaceuticals Inc SNSS.O :
* SUNESIS PHARMACEUTICALS REPORTS SECOND QUARTER 2020
FINANCIAL
RESULTS AND RECENT HIGHLIGHTS
* SUNESIS PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.06
Source text for Eikon: ID:nGNX7tCx8R
Further company coverage: SNSS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Viracta Therapeutics
See all newsBrief: Viracta Therapeutics Announces Wind Down Of Operations
Brief: Viracta Therapeutics Announces Closure Of Naval-1 Clinical Trial And Exploration Of Strategic Alternatives
Brief: Viracta Therapeutics Receives Notice Of Non-Compliance From Nasdaq
Viracta Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Viracta Therapeutics Reports Q3 2024 Financial Results And Provides Business Update